Experts to share recent case studies of how MRIoA determined over $8.5M in potential orphan drug savings and over $6.3M in just ONE specialty drug class savings.
SALT LAKE CITY, UT (October 6, 2020) – Medical Review Institute of America, an industry leader in providing external review resources will discuss the challenges Health Plans, TPAs, PBMs and Self-Insured Employers face in managing high drug costs in its October 21, 2020 webinar, Gain Control of Your Specialty and Orphan Drug Spend Starting Today. The webinar begins at 1:00 PM EST.
he specialty drug market represents approximately 50% of total drug cost in the United States today, leading to ongoing scrutiny over spending in this area.1 Orphan drug has seen a 26-fold increase in costs.2 Small and mid-market health plans, TPAs, PBMs and Self-Insured Employers may not have the specialized resources, the tools and the strategic approach in place to solve the problem of rising specialty and orphan drug costs and expenditures. To overcome this barrier, Medical Review Institute of America (MRIoA) provides evidence-based medical reviews to support innovative treatments in healthcare and ensure patients have access to the right treatment while also controlling costs.
During the webinar, industry experts will discuss:
- How to determine the appropriate use of specialty drugs which are a substantial growing class of medications in the pharmaceutical industry
- How to determine the appropriate access of specialty drugs to those in need of the medications
- How to help health plans gain control of orphan drug costs and improve outcomes
MRIoA’s webinar format includes a 30-minute presentation and a 15-minute Q&A session with experts Byron Harris, PharmD, BCPS, Senior Clinical Director for MRIoA and Jerry Frank, MD, Former Senior Vice President & Chief Medical Officer, EmblemHealth and Former National Medical Director – Clinical Analytics, United Healthcare. Interested parties can REGISTER FOR THE WEBINAR directly or contact MRIoA at info@mrioa.com, 1.800.654.2422 for further information.
About Medical Review Institute of America
Medical Review Institute of America (MRIoA) is the market-leading, technology-enabled Utilization Management (UM) and alternative care solutions company—touching over 100M lives. MRIoA partners with payers, PBMs, TPAs and self-insured employers to alleviate common strains in the UM process. MRIoA has a proven track record for perfecting the utilization review process by offering nurse, medical director, and pharmacist review solutions.
For media inquiries, please contact:
Dawn Maloney
Vice President, Marketing, MRIoA
801-265-6474
